New Trifecta Study Publication: Prospera dd-cfDNA upheld as a leading indicator for kidney transplant rejection
Satellite Symposium sponsored by Natera
Watch Video
Satellite Symposium sponsored by Natera
Watch Video
Dive into the latest data showcasing the Prospera™ test as a proven leading indicator of rejection - a critical component to any transplant care team's rejection monitoring toolkit.
Watch Video
Watch Video
Monitoring Kidney Transplant Recipients: Donor-derived Cell-free DNA (dd-cfDNA) and DSA Can Help Improve Prediction of ABMR
Watch Video